BETANCOR, Diana et al. Benralizumab is effective in severe asthma with CRS, regardless of demographic and clinical basal outcomes. Allergologia et Immunopathologia, Singapore, v. 54, n. 4, p. 162–166, 2026. DOI: 10.15586/. Disponível em: https://all-imm.com/index.php/aei/article/view/1449.. Acesso em: 1 jul. 2026.